CUE BIOPHARMA INC (CUE) Institutional Ownership Changes & 13F Activity
CUE BIOPHARMA INC (CUE). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Bleichroeder Lp, Vanguard Capital Management Llc, Lion Point Capital, Lp, Vanguard Fiduciary Trust Co, and Driehaus Capital Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| State Street Corp | Sell | -165,177 | -92.1% | 14,176 | $447.39K | Q2 2026 | Sep 22, 2026 |
| Citadel Advisors Llc | Buy | +25,633 | — | 25,633 | $808.98K | Q2 2026 | Sep 02, 2026 |
| Seven Fleet Capital Management Lp | Buy | +10,702 | — | 10,702 | $337.75K | Q2 2026 | Aug 17, 2026 |
| Lion Point Capital, Lp | Sell | -2,149,926 | -97.6% | 52,928 | $1.67M | Q2 2026 | Aug 14, 2026 |
| Driehaus Capital Management Llc | Buy | +292,144 | — | 292,144 | $9.22M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -200,779 | -96.7% | 6,929 | $218.68K | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Buy | +104,364 | — | 104,364 | $3.29M | Q2 2026 | Aug 14, 2026 |
| Diadema Partners Lp | Sell | -83,628 | -63.4% | 48,369 | $1.53M | Q2 2026 | Aug 14, 2026 |
| Stempoint Capital Lp | Buy | +66,995 | — | 66,995 | $2.11M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +55,193 | — | 55,193 | $1.74M | Q2 2026 | Aug 14, 2026 |
| Squadron Capital Management Llc | Buy | +50,000 | — | 50,000 | $1.58M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +31,459 | — | 31,459 | $992.85K | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -13,611 | -55.3% | 11,003 | $347.25K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -5,550 | -92.1% | 479 | $15.12K | Q2 2026 | Aug 14, 2026 |
| Nfsg Corp | Sell | -2,901 | -96.7% | 99 | $3.12K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Sell | -2,537 | -99.0% | 26 | $821.00 | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Sell | -252 | -84.0% | 48 | $1.51K | Q2 2026 | Aug 14, 2026 |
| Jones Financial Companies Lllp | Sell | -187 | -46.8% | 213 | $5.41K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Sell | -73 | -97.3% | 2 | $0.00 | Q2 2026 | Aug 14, 2026 |
| Group One Trading Llc | Buy | +30 | — | 30 | $947.00 | Q2 2026 | Aug 14, 2026 |
| Bleichroeder Lp | Sell | -6,448,482 | -94.6% | 370,682 | $11.70M | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Sell | -2,295,752 | -93.4% | 161,700 | $5.10M | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Sell | -519,109 | -95.5% | 24,476 | $772.46K | Q2 2026 | Aug 13, 2026 |
| Advisory Research Inc | Sell | -248,652 | -96.7% | 8,573 | $270.56K | Q2 2026 | Aug 13, 2026 |
| Renaissance Technologies LLC | Sell | -199,139 | -93.1% | 14,689 | $463.58K | Q2 2026 | Aug 13, 2026 |
| Tetragon Partners Gp Ltd | Buy | +93,819 | — | 93,819 | $2.96M | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Sell | -85,485 | -90.4% | 9,122 | $287.89K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Sell | -61,650 | -69.8% | 26,700 | $842.65K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Sell | -17,700 | -96.3% | 674 | $21.27K | Q2 2026 | Aug 13, 2026 |
| Vanguard Global Advisers, Llc | Sell | -11,360 | -87.4% | 1,637 | $51.66K | Q2 2026 | Aug 13, 2026 |
Frequently asked questions about CUE activity
Which institutional owners are buying CUE?
Institutional owners buying CUE include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CUE activity?
"Buy" means an investor increased their reported position in CUE compared to the prior reporting period. This reflects growing exposure to CUE BIOPHARMA INC (CUE) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CUE increasing?
Institutional interest in CUE can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CUE Institutional Insights
- CUE Overview
- CUE 13F Institutional Holders
- CUE Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CUE Insider Trading & SEC Form 4 Activity
- CUE Articles
- Top Institutional Investor Stock Rankings